List view / Grid view
7 October 2015 | By Victoria White
Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
3 September 2015 | By Victoria White
Horizon and Redx have announced a new research collaboration to progress Redx’s pan-RAF inhibitor programme, for out-licensing in oncology indications...
13 October 2014 | By Horizon Discovery Group
Horizon Discovery Group plc announced it has agreed to acquire Sage Labs Inc. (Sage) for up to $16M (£9.8M) in cash and up to $32M (£19.6M) through the issue of new ordinary shares...
29 September 2014 | By Horizon Discovery Group
Horizon Discovery Group plc announced it has agreed to acquire Sage Labs Inc...
25 September 2014 | By Horizon Discovery
Agreement covers development of molecular reference standards for companion diagnostics...
23 September 2014 | By Horizon Discovery
Horizon Discovery Group plc announces its interim results for the six months ended 30 June 2014...
